Head and Neck Neoplasms

• Sanofi-Aventis — Porto Salvo, Portugal
• Sanofi-Aventis — Barcelona, Spain

• University of Chicago — Chicago, Illinois, United States

• University of Chicago — Chicago, Illinois, United States

• Radboud University Nijmegen, Department of Radiotherapy — Nijmegen, Gelderland, Netherlands

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Orange, California, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Orlando, Florida, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — St. Petersburg, Florida, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Atlanta, Georgia, United States

• sanofi-aventis US — Bridgewater, New Jersey, United States
• Sanofi-Aventis — Buenos Aires, Argentina
• sanofi-aventis, Australia — Macquarie Park, New South Wales, Australia
• Sanofi-Aventis — Vienna, Austria

• University Health Network — Toronto, Ontario, Canada

• Foundation for Cancer Research and Education — Phoenix, Arizona, United States
• Stanford University Medical Center — Palo Alto, California, United States
• H-Lee Moffitt Cancer Center and Research — Tampa, Florida, United States
• University of Chicago Medical Center — Chicago, Illinois, United States

• Sanofi-Aventis — Milan, Italy

Not specified